Once-Weekly Canvuparatide Avail™ Phase 2 Trial Topline Results

MBX Biosciences Inc. published this content on September 21, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 01, 2025 at 12:50 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]